Genetic and evolutionary analysis of SARS-CoV-2 circulating in the region surrounding Islamabad, Pakistan.
Genetic and evolutionary analysis of SARS-CoV-2 circulating in the region surrounding Islamabad, Pakistan.
复制标题
DOI:
10.1016/j.meegid.2021.105003
复制
发表时间:
2021-10
期刊:
影响因子:
--
通讯作者:
Mehmood N
中科院分区:
文献类型:
--
作者:
Tamim S;Trovao NS;Thielen P;Mehoke T;Merritt B;Ikram A;Salman M;Alam MM;Umair M;Badar N;Khurshid A;Mehmood N
Genomic epidemiology of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) has provided global epidemiological insight into the COVID-19 pandemic since it began. Sequencing of the virus has been performed at scale, with many countries depositing data into open access repositories to enable in-depth global phylogenetic analysis. To contribute to these efforts, we established an Oxford Nanopore Technologies (ONT) sequencing capability at the National Institutes of Health (NIH), Pakistan. This study highlights multiple SARS-CoV-2 lineages co-circulating during the peak of a second COVID-19 wave in Pakistan (Nov 2020-Feb 2021), with virus origins traced to the United States of America and Saudi Arabia. Ten SARS-CoV-2 positive samples were used for ONT library preparation. Sequence and phylogenetic analysis determined that the patients were infected with lineage B.1.1.250, originally identified in the United Kingdom and Bangladesh during March and April of 2020, and in circulation until the time of this study in Europe, USA and Australia. Lineage B.1.261 was originally identified in Saudi Arabia with widespread local dissemination in Pakistan. One sample clustered with the parental B.1 lineage and the other with lineage B.6 originally from Singapore. In the future, monitoring the evolutionary dynamics of circulating lineages in Pakistan will enable improved tracing of the viral spread, changing trends of their expansion trajectories, persistence, changes in their demographic dynamics, and provide guidance for better implementation of control measures.
登录
查看更多内容
DOI:
10.1016/j.lanwpc.2021.100104
发表时间:
2021-03
期刊:
The Lancet regional health. Western Pacific
影响因子:
--
作者:
Nabeshima T;Takazono T;Ashizawa N;Miyazaki T;Inoue S;Ngwe Tun MM;Izumikawa K;Mukae H;Moi ML;Morita K
通讯作者:
Morita K
DOI:
10.1016/j.cub.2011.05.058
发表时间:
2011-08-09
期刊:
Current biology : CB
影响因子:
--
作者:
Edwards CJ;Suchard MA;Lemey P;Welch JJ;Barnes I;Fulton TL;Barnett R;O'Connell TC;Coxon P;Monaghan N;Valdiosera CE;Lorenzen ED;Willerslev E;Baryshnikov GF;Rambaut A;Thomas MG;Bradley DG;Shapiro B
通讯作者:
Shapiro B
影响因子:
9.5
作者:
Katoh K;Rozewicki J;Yamada KD
通讯作者:
Yamada KD
影响因子:
64.8
作者:
Grubaugh ND;Ladner JT;Kraemer MUG;Dudas G;Tan AL;Gangavarapu K;Wiley MR;White S;Thézé J;Magnani DM;Prieto K;Reyes D;Bingham AM;Paul LM;Robles-Sikisaka R;Oliveira G;Pronty D;Barcellona CM;Metsky HC;Baniecki ML;Barnes KG;Chak B;Freije CA;Gladden-Young A;Gnirke A;Luo C;MacInnis B;Matranga CB;Park DJ;Qu J;Schaffner SF;Tomkins-Tinch C;West KL;Winnicki SM;Wohl S;Yozwiak NL;Quick J;Fauver JR;Khan K;Brent SE;Reiner RC Jr;Lichtenberger PN;Ricciardi MJ;Bailey VK;Watkins DI;Cone MR;Kopp EW 4th;Hogan KN;Cannons AC;Jean R;Monaghan AJ;Garry RF;Loman NJ;Faria NR;Porcelli MC;Vasquez C;Nagle ER;Cummings DAT;Stanek D;Rambaut A;Sanchez-Lockhart M;Sabeti PC;Gillis LD;Michael SF;Bedford T;Pybus OG;Isern S;Palacios G;Andersen KG
通讯作者:
Andersen KG
DOI:
10.1016/j.jhin.2016.10.008
发表时间:
2017-03
期刊:
The Journal of hospital infection
影响因子:
--
作者:
Kim KH;Tandi TE;Choi JW;Moon JM;Kim MS
通讯作者:
Kim MS